![James Wassil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Wassil
Geschäftsführer bei
VAXCYTE, INC.
Vermögen: 8 Mio $ am 31.05.2026
Profil
James Wassil is Chief Operating Officer & Executive Vice President at Vaxcyte, Inc. since 2019.
Former roles include Director and Independent Director at Icosavax, Inc. from 2022 to 2024, Vice President-Global Health & Value Business at Pfizer Inc. from 2015 to 2019, Head-Global Product Development at Novartis AG from 2008 to 2015, and Senior Director-International Marketing at Merck & Co., Inc. from 1992 to 2008.
Education includes undergraduate studies at the University of Notre Dame and graduate studies including an MBA at Lehigh University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXCYTE, INC. 0.11% | 01.06.2026 | 158’494 ( 0.11% ) | 8 Mio $ | 31.05.2026 |
Aktive Positionen von James Wassil
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXCYTE, INC. | Geschäftsführer | 01.12.2019 |
Ehemalige bekannte Positionen von James Wassil
| Unternehmen | Position | Ende |
|---|---|---|
| ICOSAVAX, INC. | Direktor/Vorstandsmitglied | 19.02.2024 |
| ICOSAVAX, INC. | Direktor/Vorstandsmitglied | 01.02.2024 |
| PFIZER INC. | Corporate Officer/Principal | 01.12.2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01.05.2015 |
| MERCK & CO., INC. | Vertrieb & Marketing | 01.01.2008 |
Ausbildung von James Wassil
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a medical association representing physicians, scientists, and other healthcare professionals | Commercial Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Icosavax, Inc.
 Icosavax, Inc. BiotechnologyHealth Technology Develops vaccines for infectious disease | Health Technology |
